"Adiponectin Can Affect ER Signaling in Obese Breast Cancer Patients"
written by Rana Jahanban Esfahlan, Nosratollah Zarghami, Samira Valiyari, Hamed Farshbaf Kamel, Maryam Daneshvar, Ali Jahanban Esfahlan, Majid Mobasseri, Kazem Nejati-Koshki,
published by Journal of Cancer Therapy, Vol.3 No.1, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Hesa-A Improves Clinical Outcome of Oral Carcinoma by Affecting p53 Gene Expression in vivo.
Asian Pacific journal of cancer prevention: APJCP, 2015
[2] Hesa-A Improves Clinical Outcome of Oral Carcinoma by Affecting p53 Gene Expression in vivo
2015
[3] Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model
2015
[4] Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV …
2014
[5] Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 …
2014
[6] New formulated “DOX-MTX-loaded nanoparticles” downregulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of …
2014
[7] DOXMTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes
2014
[8] New formulated “DOX-MTX-loaded nanoparticles” downregulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of …
2014
[9] Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflammatory properties in non-obese women
Molecular and cellular …, 2014
[10] Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities
Asian Pacific journal …, 2014
[11] New formulated “DOX-MTX-loaded Nanoparticles” Down-regulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities
Asian Pacific Journal of Cancer Prevention, 2014
[12] DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes
Asian Pacific Journal of Cancer Prevention, 2014
[13] Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo.
Asian Pacific journal of cancer prevention: APJCP, 2014